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Abstract 
Purpose The aim of this study was to assess the ability of real-time breathhold 
triggered myocardial perfusion imaging (MPI) using a novel cadmium-zinc-telluride 
(CZT) gamma camera to discriminate artefacts from real perfusion defects. 
Methods Forty patients underwent a one-day 99mTc-tetrofosmin pharmacologic 
stress/rest imaging protocol on a conventional dual-detector SPECT gamma camera 
with and without attenuation correction (AC) immediately followed by scanning on an 
ultrafast CZT camera with and without real-time breathhold triggering (instead of AC) 
by intermittent scanning confined to breath-hold at deep inspiration (using list mode 
acquisition). We studied the use of breathhold triggering on the CZT camera and its 
ability to discriminate artefacts from real perfusion defects using AC SPECT-MPI as 
standard of reference. Myocardial tracer uptake (percent of maximum) from CZT was 
compared to AC SPECT-MPI by intraclass correlation and by calculating Bland-
Altman limits of agreement. 
Results AC of SPECT-MPI identified 19 perfusion defects as artefacts. Of these, 13 
were correctly identified and 4 were partially unmasked (decrease in extent and/or 
severity) by breathhold triggering of the CZT scan. All perfusion defects verified by 
SPECT-MPI with AC were appropriately documented by CZT with and without 
breathhold triggering. This is supported by the quantitative analysis, as correlation (r) 
of myocardial tracer uptake between CZT and AC SPECT improved significantly from 
0.81 to 0.90 (p<0.001) when applying breathhold triggering. Similarly, Bland-Altman 
limits of agreement were narrower for breathhold triggered CZT scans. 
Conclusions This novel CZT camera allows real-time breathhold triggering as a 
potential alternative to AC for assisting to discriminate artefacts from real perfusion 
defects. 
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Introduction 
Myocardial perfusion imaging (MPI) plays a key role in the non-invasive assessment 
of cardiac disease including prediction of prognosis and choice of adequate 
treatment strategies for patients with known or suspected ischemic coronary artery 
disease (CAD) [1]. However, although MPI is a valuable clinical tool, it is 
nevertheless subject to a variety of artefacts and potential pitfalls, which may affect 
its clinical utility [2].  
Common sources of artefacts in MPI studies are attenuation of photons by the 
patient’s body as well as prominent sub-diaphragmatic gastrointestinal activity which 
typically interferes with the adjacent inferior myocardial wall and may either lead to 
increased activity (due to spill-over) or to apparently decreased activity (caused by 
hot-spots).  
Several strategies to address these problems and to discriminate artefacts from 
perfusion defect have been proposed such as scanning in prone position [3], 
integrating findings from gated SPECT [4], and attenuation correction (AC) using line 
sources [5] or low-dose CT [6]. As an alternative for improving SPECT image quality, 
respiratory gating has been suggested [7-11] but has remained challenging due to 
the step-and-shoot acquisition mode in SPECT gamma cameras with rotating 
detectors. 
The introduction of a novel generation of gamma cameras using cadmium-zinc-
telluride (CZT) detectors may at least in part help to overcome these drawbacks and 
limitations. The miniaturized CZT detectors and a multi-pinhole design enables an 
alignment of the detectors around the patient, thus covering the entire heart at all 
times and rendering camera rotation around the patient unnecessary allowing for a 
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more than five-fold shortening of the scan time [12, 13]. In addition, this enables 
intermittent scanning which, in combination with list mode acquisition, allows 
breathhold triggering.  
Thus, the aim of the present study was to assess the ability of real-time 
breathhold triggering of CZT scanning to discriminate MPI artefacts from real 
perfusion defects using AC of SPECT-MPI as standard of reference.
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Subjects and methods 
Study Protocol and image acquisition 
Forty patients referred to SPECT-MPI for evaluation of CAD underwent a one-day 
99mTc-tetrofosmin stress/rest MPI protocol as suggested by the guidelines of the 
European Association of Nuclear Medicine [14]. Scanning for stress and rest was 
performed first on a conventional dual-detector SPECT gamma camera (Ventri, GE 
Healthcare). Scan duration was 14 minutes and 52 seconds for both, stress and rest. 
Each scan was repeated within minutes on an ultrafast CZT camera (Discovery 530 
NMc, GE Healthcare) once with regular acquisition, i.e. with normal breathing, and a 
second time with real-time breathhold triggering. Therefore, patients were repeatedly 
told to perform a breathhold at a deep inspiration-level while scanning was manually 
initiated after end-inspiration to ensure confinement of acquisition to breath-hold at 
deep inspiration. After scanning at breathhold for a duration (10 - 20 seconds) which 
had been individually determined according to the patient’s ability, acquisition was 
manually interrupted and the patient was allowed to breathe normally before 
continuing the scan. This sequence was repeated until an overall scan duration of 3 
minutes for stress and 2 minutes for rest was reached as previously established for 
this camera [12, 13]. 
Pharmacological stress was induced by standard adenosine or dobutamine 
infusion [14]. 99mTc-tetrofosmin injection was administered after 3 minutes of induced 
stress. Injection was followed by a waiting time of 90 minutes before image 
acquisition on both cameras. Rest MPI was performed thereafter with the identical 
acquisition protocol after injection of a 3 times higher dose of 99mTc-tetrofosmin.  
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Acquisition on the conventional dual-head SPECT camera was performed using a 
low-energy, high-resolution collimator, a 20 % symmetric window at 140 keV, a 64 x 
64 matrix, and an elliptic orbit with step-and-shoot acquisition at 3 degrees intervals 
over a 180 degree arc (45 degrees anterior oblique to 45 degrees left posterior 
oblique) with 30 steps (60 views). Electrocardiogram-gated scans were acquired 
using 16 bins. Scan time was set to 25 seconds per frame for stress and rest, 
resulting in a total scan time (including inter-step rotation time) of 14 minutes and 52 
seconds according to the guidelines [14].  
Scans on the CZT camera were acquired using a multi-pinhole collimator 
(effective diameter aperture of 5.1 mm) and 19 stationary detectors simultaneously 
imaging 19 views of the heart. Each detector contains 32 x 32 pixilated (2.46 x 2.46 
mm) CZT elements. Image acquisition was performed using list mode. A 10 % 
symmetric energy window at 140 keV was used. Electrocardiogram-gated scans 
were acquired using 16 bins. Scans on the CZT camera were acquired over 3 
minutes for stress and 2 minutes for rest, as recently established [12, 13]. As the 
CZT detectors are aligned around the patient, covering the entire heart, acquisition of 
all cardiac views simultaneously is possible, as opposed to the SPECT acquisition. 
The study protocol was approved by the local ethics committee and written 
informed consent was obtained from every patient. 
 
CT attenuation correction 
To create CT AC maps all patients underwent an unenhanced 64-slice CT 
examination on a Light Speed VCT Scanner (GE Healthcare) during breath hold as 
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previously reported [6]. The scans covered the entire heart using prospectively 
electrocardiogram triggered sequential images at 75 % of the R-R interval, 2.5 mm 
section thickness, and 0.35 s gantry rotation time at 120 kV and 200 mA, depending 
on the patient’s BMI. CT images were reconstructed with 5 mm thickness by using a 
reconstruction algorithm with a 512 x 512 matrix and a full-chest-size-adapted field-
of-view of 50 x 50 cm. The reconstructed CT images were then transferred to a 
Xeleris workstation (GE Healthcare) for AC map creation. 
 
MPI reconstruction 
Images of the conventional SPECT camera were reconstructed with and without CT 
AC on a dedicated workstation using a standard iterative reconstruction algorithm 
with Ordered Subset Expectation Maximization (OSEM). CZT images were 
reconstructed on the same workstation using a dedicated iterative algorithm with 
Maximum Likelihood Expectation Maximization (MLEM). Perfusion images in 
standard axis (short axis, vertical long axis, horizontal long axis) and polar maps of 
the left ventricle were obtained.  
 
Visual analysis 
Scans from both, conventional SPECT and CZT were analyzed in consensus by two 
experienced readers blinded to any information on patient identification or the utilized 
camera or acquisition type. Cardiac perfusion was assessed on a per patient basis 
and for each vessel territory with regard to severity using a 5-point scale (1 = normal, 
2 = equivocal, 3 = perfusion defect with moderate decrease of uptake, 4 = severe 
decrease of uptake, 5 = absent perfusion) and extent using a 3-point scale (1 = small, 
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2 = moderate, 3 = large), as previously reported [15]. Agreement and discrepancies 
in severity and extent between conventional SPECT with and without AC and 
between CZT with and without breathhold triggering were recorded per patient and 
per coronary territory. The former served as standard of reference, as CT AC is not 
yet validated for this novel CZT camera system. Image quality was assessed 
subjectively on a four-point scale (1 = poor, 2 = fair, 3 = good, 4 = excellent) with the 
following parameters being considered: myocardial count density and uniformity, 
endocardial and epicardial edge definition, and background noise 
 
Quantitative analysis 
The software package Myovation for Alcyone (GE Healthcare) was used for 
quantitative analysis on MPI polar maps using a 20 segment model for the left 
ventricle. Uptake was normalized to 100 % peak activity and relative myocardial 
uptake (percent of maximum myocardial uptake) was assessed for each vessel 
territory (LAD: segments 1, 2, 7, 8, 13, 14, 15, 19, and 20; LCX: segments 5, 6, 11, 
12, 17, 18; RCA: segments 3, 4, 9, 10, 16) from SPECT and CZT data.  Automated 
analysis on gated acquisitions from high-dose (rest) scans was performed to 
determine left ventricular ejection fraction (LVEF). 
 
Statistics 
SPSS 17.0 (SPSS Inc.) was used for statistical testing. Quantitative variables were 
expressed as mean ± standard deviation and categorical variables as frequencies or 
percentages. The correlation of tracer uptake and LVEF between AC SPECT and 
 9
CZT with and without breathhold triggering was evaluated using intraclass correlation 
analysis (absolute agreement) and Fisher's Z-transformation was used to compare 
correlation coefficients. In addition, Bland-Altman (BA) limits of agreement were 
calculated. P values of less than 0.05 were considered statistically significant and the 
95 % confidence intervals are presented. 
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Results 
Patient characteristics are given in Table 1. Patients were referred to nuclear MPI for 
the following reasons: suspected CAD (n = 25; 62 %), follow-up of a known CAD (n = 
14; 35 %), preoperative risk assessment before major non-cardiac surgery (n = 1; 
3 %). In 39 (97 %) patients pharmacological stress was induced with adenosine and 
in 1 patient (3 %) with dobutamine. For stress and rest mean doses of 327 ± 25 MBq 
(range 292 - 414 MBq) and 940 ± 47 MBq (range 900 - 1180 MBq) 99mTc-tetrofosmin 
were administered, respectively. All 40 patients underwent MPI on both cameras and 
real-time breathhold triggering was successfully performed in all patients. 
 
Visual analysis 
Image quality was good or excellent in 36 (90 %) and fair in 4 (10 %) patients for the 
conventional SPECT-MPI without AC. After AC, image quality of SPECT-MPI was 
good or excellent in 37 (93 %) patients and fair in 3 (7 %) patients. Image quality of 
CZT without breathhold triggering was good or excellent in 35 (87 %), fair in 4 (10 %), 
and poor in 1 (3 %) patients. Breathhold triggered CZT scans resulted in good or 
excellent image quality in 39 (97 %) of patients and in fair image quality in 1 patient 
(3 %). Gastrointestinal tracer activity adjacent to the myocardial wall was found in 
both, SPECT and CZT scans of nine patients. 
Uncorrected SPECT scans showed 19 perfusion defects which disappeared after 
applying AC and were therefore identified as artefacts, predominantly located in the 
RCA territory (Figure 1A). All 19 artefacts were also present in the non-triggered CZT 
scans. After breathhold triggering 13 artefacts disappeared and 4 were at least 
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partially unmasked as they were substantially decreased in extent and/or severity. 
One additional defect, only present in CZT but not in SPECT-MPI, was appropriately 
identified as an artefact by breathhold triggering. The latter was most successful in 
the RCA territory (Figure 1B). 
AC SPECT-MPI revealed true myocardial perfusion defects in 16 scans (5 fixed 
and 6 reversible defects) in 11 patients. All corresponding defects were equally 
identified by CZT scans with and without breathhold triggering, indicating that the 
gain in specificity (i.e. the unmasking of defects as artefacts) was not achieved at the 
cost of a decrease in sensitivity. Of note, 5 defects in the RCA territory confirmed as 
true defects by CT AC SPECT were also identified by CZT with and without 
breathhold triggering, indicating specifically in this territory which was most prone to 
artefacts that the corrections were not over-corrections. 
Figure 2 illustrates the impact of AC and breathhold triggering on artefacts in 
SPECT-MPI and CZT-MPI, respectively. 
 
Quantitative analysis 
The intraclass correlation coefficient (r) of the myocardial tracer uptake comparison 
between conventional AC SPECT-MPI and CZT without breathhold triggering was 
0.81 (95 % CI: 0.63 - 0.88, p < 0.001) and improved significantly (p < 0.001) by 
breathhold triggering of CZT to 0.90 (95 % CI: 0.85 - 0.93, p < 0.001). 
Consequently, when comparing CZT to conventional AC SPECT scans, BA limits 
of agreement for percent myocardial tracer uptake narrowed from -17 to 9 % for CZT 
without breathhold triggering to -12 to 8 % for CZT with breathhold triggering.  
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The quantitative comparison of the LVEF between SPECT and CZT without 
breathhold triggering resulted in an intraclass correlation coefficient of 0.92 (95 % CI: 
0.84 - 0.96; p < 0.001) and BA limits of agreement of -17 to 12 %. This comparability 
remained unaffected after breathhold triggering with a correlation coefficient of 0.93 
(95 % CI: 0.80 - 0.97; p < 0.001) and BA limits of agreement of -16 to 8 % for 
breathhold triggered CZT scans. 
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Discussion 
Artificial perfusion defects due to tissue attenuation and/or gastrointestinal tracer 
activity is not uncommon in MPI but may be overcome by appropriate AC. In the 
present study AC revealed 19 such perfusion defects of SPECT-MPI as artefacts. 
Similarly, breathhold triggering identified 13 of these perfusion defects in the CZT 
scans as artefacts, and additionally led to a partial unmasking of 4 of the remaining 6 
artefacts by substantially decreasing the extent and/or severity of the perfusion 
defect. Breathhold triggering was most effective in patients with sub-diaphragmatic 
tracer activity and in obese patients with attenuation artefacts in the RCA territory 
where most of the artefacts where located (Figure 1). Conversely, in the present 
study, CZT scans with breathhold triggering correctly identified all perfusion defects 
that were confirmed as true defects by AC. Thus, applying breathhold triggering has 
successfully increased specificity for discriminating true defects from artefacts 
without affecting sensitivity to detect defects. 
Several different approaches have been described to improve reader confidence 
in SPECT-MPI by identifying defects caused by tissue attenuation or sub-
diaphragmatic tracer activity as artefacts. Among those, the most efficient and 
accurate technique is AC based on transmission data obtained either by an 
additional rotating isotope or by CT [14]. However, AC may on the other hand 
potentially introduce artefacts, particularly in the presence of sub-diaphragmatic 
tracer activity [16]. Similarly, scanning in the prone position to correct for inferior 
attenuation has been associated with artificial anteroseptal defects [3].  
Consequently, even when applying any of the above procedures for AC, image 
interpretation should still integrate all available patient information, including obesity 
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and gender as well as wall motion analysis from electrocardiogram-gated SPECT [4, 
17] as this increases accuracy and reader confidence on whether a defect should be 
classified as artificial or real. 
The present study demonstrates that real-time breathhold triggering confining the 
image acquisition to breath-hold at deep inspiration levels may serve as an 
alternative to CT AC, as it unmasked the majority of artefacts. This was particularly 
successful in the RCA-territory (79 % of artefacts unmasked, Figure 1B) where most 
of the attenuation artefacts were found, in line with a large body of literature (Figure 
1A) [14]. 
The concept of breathhold gating is not entirely new [7-11]. However, most 
previous reports have focused on retrospective respiratory gating using rotating dual-
head SPECT gamma cameras requiring either an increase in activity or a 
prolongation of the acquisition time, rendering the procedure very cumbersome. In 
addition, retrospective gating does not allow scanning at forced inspiration as such 
controlled breathing is not feasible over a prolonged period of 20 to 30 minutes. 
These drawbacks have so far hampered introduction of respiratory gating for 
SPECT-MPI into daily clinical routine. By contrast, the present study validates the 
use of real-time breathhold triggering with breath hold at maximal inspiration, 
overcoming the above drawbacks and potentially paving the way for its introduction 
into clinical use. 
Attenuation artefacts have for a long time been recognized to affect specificity of 
nuclear MPI. Although recently low-dose CT has emerged as an excellent tool for 
accurate AC [6], the need of an integrated SPECT-CT device with increased costs or 
the time consuming repositioning of the patient into a standalone CT  scanner have 
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limited its widespread use. Similarly, the vast majority of latest generation gamma 
cameras with CZT detectors will not be equipped with a CT facility. Therefore, real-
time breathhold triggered CZT-MPI offers a welcome alternative to CT-AC for 
discriminating artefacts from real perfusion defects. 
It may be perceived as a limitation of this study that we did not use invasive 
coronary angiography as standard of reference. However, this study was aimed at 
evaluating the impact of real-time breathhold triggering on MPI. We felt that it was 
more adequate to use a reference image modality directly reflecting myocardial 
perfusion while invasive coronary angiography would be a flawed standard of 
reference as anatomical findings do not necessarily reflect the underlying 
hemodynamic situation. The use of any other non-SPECT MPI such as MRI or PET 
would have inferred many technical differences and would have required complex 
protocols with co-injection of the respective flow tracer. Therefore, we have used CT 
AC SPECT as standard of reference, as CT-based AC for SPECT has been showed 
to improve accuracy [18]. Finally, breathhold may potentially pose a problem in 
patients with dyspnoea. However, the advantage of the present protocol is that – in 
contrast to breathhold for CT scanning – the duration of breathhold can be dictated 
by the patients ability. This may have positively influenced patients’ comfort. 
 
Conclusion 
We have established a protocol for real-time breathhold triggering of MPI on a novel 
CZT gamma camera as a potential alternative to AC for assisting to discriminate 
artefacts caused by soft-tissue attenuation or sub-diaphragmatic tracer activity from 
real perfusion defects. 
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Figure legends 
 
 
Fig. 1 Artefacts (as determined by AC SPECT-MPI) were predominantly present in 
the RCA territory (A). Respiratory triggering proved most successful in identifying 
artefacts in the RCA territory (B). (* LAD vs. LCX: non significant; † LAD vs. RCA: p < 
0.05; ‡ LCX vs. RCA: p < 0.05) 
 
 
 
Fig. 2 SPECT-MPI without AC (A) and CZT-MPI without breathhold triggering (B) 
showed an inferior perfusion defect which was identified as artificial as it disappeared 
in SPECT-MPI after AC (C) and in CZT-MPI after breathhold triggering (D).  


 Table 1 Patient baseline characteristics (n = 40) 
Male 24 (60 %) 
Age (years)  
 Mean ± SD 66 ± 10 
 Range 43 - 81 
BMI (kg / m2)  
 Mean ± SD 26 ± 4 
 Range 19 - 34 
Cardiovascular risk factors  
 Obesity (BMI > 30 kg / m2) 7 (18 %) 
 Smoking 9 (23 %) 
 Diabetes mellitus 7 (18%) 
 Hypertension 27 (68%) 
 Dyslipidemia 20 (50 %) 
 Positive family history 5 (13 %) 
Clinical symptoms  
 Typical angina pectoris 2 (5 %) 
 Atypical chest pain 21 (53 %) 
 Dyspnea 3 (8%) 
 No cardiac symptoms 14 (35 %) 
Current cardiac medication  
 Aspirin 21 (53 %) 
 Betablocker 16 (40%) 
 ACE-/Angiotensin-II-Inhibitor 17 (43 %) 
 Statin 21 (53 %) 
SD = standard deviation, BMI = body mass index,  
ACE = angiotensin converting enzyme 
 
 
 
Revised Table 1
